Context.—Although a large number of women of reproductive age use new selective serotonin
reuptake inhibitors (SSRIs) and half of all pregnancies are unplanned, no data exist on …

Background To determine whether the orally active iron chelator deferiprone (1,2-dimethyl-3-hydroxypyridin-4-one)
is efficacious in the treatment of iron overload in patients with …

… Doreen Matsui reviewed recommendations by different agencies and critically reviewed
all … All of the authors are members, and Doreen Matsui is the chairperson, of the Canadian …

OBJECTIVE: Because there are no studies available on the safety of venlafaxine during
pregnancy, the authors’ goal in this study was to determine whether venlafaxine increases the …

Compliance with therapy has a significant role in clinical practice and medical research.
Although the application of modern technology to the assessment of compliance has led to a …

Background and aim: The safety of bisphosphonates in human pregnancy has not been well
established. To characterize pregnancy outcome in women receiving bisphosphonates, we …

During the last decade critical new information has been published pertaining to folic acid
supplementation in the prevention of neural tube defects (NTDs) and other folic acid–sensitive …

With the recent emphasis on investigating the efficacy of medication in children, it is also
important to assess what determines whether pediatric patients do or do not take their …

Objectives: Trazodone and nefazodone are phenylpiperazine antidepressants. Currently,
there are no adequate, well-controlled studies on the fetal safety of these drugs. Our primary …

Available information suggests that nonadherence with medication is a common problem in
pregnant women. Not taking prescribed drugs may have potentially negative consequences …